|
|
||||||||
Department of Microbiology and Pathology, Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908
Complement proteins are involved in early innate immune responses
against pathogens and play a role in clearing circulating viral Ags
from the blood of infected hosts. We have previously demonstrated that
hepatitis C virus (HCV) core, the first protein to be expressed and
circulating in the blood of infected individuals, inhibited human T
cell proliferative response through interaction with the complement
receptor, globular domain of C1q receptor (gC1qR). To
investigate the mechanisms of HCV core/gC1qR-induced inhibition of T
cell proliferation, we examined the effect of core protein on the early
events in T cell activation. We found that HCV core inhibited
phosphorylation of extracellular signal-regulated kinase (ERK) and
mitogen-activated ERK kinase (MEK). HCV core-induced impairment
of ERK/MEK mitogen-activated protein kinase resulted in the inhibition
of IL-2 and IL-2R
gene transcription, which led to the inhibition of
IL-2 production and high-affinity IL-2R expression. Importantly, the
ability of anti-gC1qR Ab treatment to reverse HCV core-induced
inhibition of ERK/MEK phosphorylation reveals that the interaction
between HCV core and gC1qR is linked to the interference of ERK/MEK
mitogen-activated protein kinase activation. These results imply that
HCV core-induced blockage of intracellular events in T cell activation
by a complement-dependent regulatory pathway may play a critical role
in the establishment of HCV persistence during the acute phase of viral
infection.
This article has been cited by other articles:
![]() |
D. Sansonno, F. A. Tucci, B. Ghebrehiwet, G. Lauletta, E. I. B. Peerschke, V. Conteduca, S. Russi, P. Gatti, L. Sansonno, and F. Dammacco Role of the Receptor for the Globular Domain of C1q Protein in the Pathogenesis of Hepatitis C Virus-Related Cryoglobulin Vascular Damage J. Immunol., November 1, 2009; 183(9): 6013 - 6020. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ebinuma, N. Nakamoto, Y. Li, D. A. Price, E. Gostick, B. L. Levine, J. Tobias, W. W. Kwok, and K.-M. Chang Identification and In Vitro Expansion of Functional Antigen-Specific CD25+ FoxP3+ Regulatory T Cells in Hepatitis C Virus Infection J. Virol., May 15, 2008; 82(10): 5043 - 5053. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Jerome Viral Modulation of T-Cell Receptor Signaling J. Virol., May 1, 2008; 82(9): 4194 - 4204. [Full Text] [PDF] |
||||
![]() |
J. R. Lukens, M. W. Cruise, M. G. Lassen, and Y. S. Hahn Blockade of PD-1/B7-H1 Interaction Restores Effector CD8+ T Cell Responses in a Hepatitis C Virus Core Murine Model J. Immunol., April 1, 2008; 180(7): 4875 - 4884. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Jeong, Y.-J. Lee, S.-K. Seo, S.-W. Lee, S.-J. Park, J.-N. Lee, H.-S. Sohn, S. Yao, L. Chen, and I. Choi Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection J. Leukoc. Biol., March 1, 2008; 83(3): 755 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Waggoner, C. H. T. Hall, and Y. S. Hahn HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production J. Leukoc. Biol., December 1, 2007; 82(6): 1407 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sansonno, A. Carbone, V. De Re, and F. Dammacco Hepatitis C virus infection, cryoglobulinaemia, and beyond Rheumatology, April 1, 2007; 46(4): 572 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Q. Yao, S. N. Waggoner, M. W. Cruise, C. Hall, X. Xie, D. W. Oldach, and Y. S. Hahn SOCS1 and SOCS3 Are Targeted by Hepatitis C Virus Core/gC1qR Ligation To Inhibit T-Cell Function J. Virol., December 15, 2005; 79(24): 15417 - 15429. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Eisen-Vandervelde, S. N. Waggoner, Z. Q. Yao, E. M. Cale, C. S. Hahn, and Y. S. Hahn Hepatitis C Virus Core Selectively Suppresses Interleukin-12 Synthesis in Human Macrophages by Interfering with AP-1 Activation J. Biol. Chem., October 15, 2004; 279(42): 43479 - 43486. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Q. Yao, A. Eisen-Vandervelde, S. N. Waggoner, E. M. Cale, and Y. S. Hahn Direct Binding of Hepatitis C Virus Core to gC1qR on CD4+ and CD8+ T Cells Leads to Impaired Activation of Lck and Akt J. Virol., June 15, 2004; 78(12): 6409 - 6419. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Lee, R.-F. Chen, J.-W. Liu, W.-T. Yeh, J.-C. Chang, P.-M. Liu, H.-L. Eng, M.-C. Lin, and K. D. Yang Altered p38 Mitogen-Activated Protein Kinase Expression in Different Leukocytes with Increment of Immunosuppressive Mediators in Patients with Severe Acute Respiratory Syndrome J. Immunol., June 15, 2004; 172(12): 7841 - 7847. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dolganiuc, K. Kodys, A. Kopasz, C. Marshall, T. Do, L. Romics Jr., P. Mandrekar, M. Zapp, and G. Szabo Hepatitis C Virus Core and Nonstructural Protein 3 Proteins Induce Pro- and Anti-inflammatory Cytokines and Inhibit Dendritic Cell Differentiation J. Immunol., June 1, 2003; 170(11): 5615 - 5624. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ni, E. Hembrador, A. M. Di Bisceglie, I. M. Jacobson, A. H. Talal, D. Butera, C. M. Rice, T. J. Chambers, and L. B. Dustin Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients J. Immunol., March 15, 2003; 170(6): 3429 - 3439. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Urbani, C. Boni, G. Missale, G. Elia, C. Cavallo, M. Massari, G. Raimondo, and C. Ferrari Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and C J. Virol., November 13, 2002; 76(24): 12423 - 12434. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Soguero, M. Joo, K. A. Chianese-Bullock, D. T. Nguyen, K. Tung, and Y. S. Hahn Hepatitis C Virus Core Protein Leads to Immune Suppression and Liver Damage in a Transgenic Murine Model J. Virol., August 12, 2002; 76(18): 9345 - 9354. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |